Scientific Agenda Conference Day – 1 |
||||
Time |
Hall A |
Hall B |
Hall C |
Hall D |
8.00 AM Onwards |
REGISTRATION |
REGISTRATION |
REGISTRATION |
REGISTRATION |
09.00 – 10.00 AM |
Oral Paper (Selected 6) |
Oral Paper (Selected 6) |
Oral Paper (Selected 6) |
Oral Paper (Selected 6) |
10.00 – 11.00 AM |
Session 1 Chairperson: - |
Session 2 Chairperson: - |
Session 3 Chairperson: - |
Session 4 Chairperson: - |
10.00 – 10.20 AM |
Thrombotic APLA : Diagnosis and management updates Speaker: Dr.Vidisha Mahajan |
Thalassemia - refresher for primary care physicians Speaker: Dr. |
Nurses role in Setting up of bone marrow transplant unit Speaker: Dr(Prof) Vijay Kumar |
Stains in hematology Speaker: Dr.Mita Roychowdhury |
10.20 – 10.40 AM |
Pregnancy in sickle cell anaemia Speaker: Dr.Dilip Gohokar |
Splenectomy in hemolytic anemia - when and how Speaker: Dr.Nilesh Wasekar |
Infection control practices in bone marrow transplant unit Speaker: Dr.Nadhiya.G |
Trouble shooting in coagulation lab Speaker: Dr.Bhawna Sahu (Metropolis) |
10.40 – 11.00 AM |
HITT and VITT - Diagnosis and approach Speaker: Dr.Tribikram Panda |
TDT and NTDT - Iron chelation and monitoring Speaker: Dr.Amit Khurana |
Incorporation of PEWs in Care of neutropenic child Sangeeta Choini Speaker: |
Quality assurance in hematology lab Speaker: Dr.Nabhajit Mallik |
11.00 - 11:30 AM |
Tea break |
|||
11.30 – 1.00 PM |
Session 5 Chairperson: - |
Session 6 Chairperson: - |
Session 7 Chairperson: - |
Session 8 Chairperson: - |
11.30 – 11.50 AM |
Cancer associated thrombosis : Speaker: Dr.Vikas Goyal |
Stem cell transplant - Basics Speaker: Dr.Dibyendu De |
Best practices and advancements in blood transfusion in BMT Speaker: Dr.Snehil Kumar |
Setting up a molecular laboratory. Speaker: Dr. Shivangi Harankhedkar(IMS SUM BBSR) |
11.50 AM – 12.10 PM |
Central venous access devices associated thrombosis Speaker: Dr.Deepika Gupta |
Indications of stem cell transplant in current era Speaker: Dr.Rajib De |
Nutritional care in haematology patient: Role of the nurse Speaker: Ms.Minori Ramteke(Dietician HCG) |
Types of PCR and applications. Speaker: Dr.Priyanka Mishra |
12.10 – 12.30 PM |
Peri operative anti coagulation management Speaker: Dr.Shweta Kothari |
Pre transplant work-up and LTFU program Speaker: Dr.Suraj Chiraniya |
Care of the indwelling access device Speaker: Dr.Margaret Devathanam |
Cytogenetics studies in haematology:Tools Speaker: Dr.Anurag Gupta |
12.30 – 12.50 PM |
Mannagement of thrombosis at unusual sites Speaker: Dr.Vishnu Sharma |
Complications of BMT Speaker: Dr.Venkatesh Ekbote |
Accreditation and Certification: Ensuring high standards in nursing practice and education Speaker: Dr.Amrita Gope |
Diagnosis of platelet function disorders - Nuances Speaker: Dr.Rajesh Bhola (IMS SUM bbsr) |
1.00 – 2.00 PM |
Lunch |
|||
2.00 – 3.00 PM |
Session-9 Chairpersons: Dr. Mrs Tayade, Dr.Chetan Sharma & Dr. Y Thakkar |
Session-10 Chairpersons: Dr.Rajive Kumar(Mahavir cancer) & Dr.Ruchi Sinha(AIIMS Patna) , Dr.Anju Kadu |
Session-11 Chairpersons: Dr.Shailesh Bamborde & Dr.Ashish Vaidya |
Session-12 Chairpersons: Dr.Mishra & Dr.Ponkshe |
2.00 – 2.20 PM |
Atypical infections in hematology Speaker: TBA |
Approach to the patient with excessive bleeding Speaker: Dr.R Manchanda |
Management of Cytotoxic drug induced Extravasation Speaker: Dr.Sriparna Giri |
Work up of Hemoglobinopathies Speaker: Dr.Gurpreet Sagoo |
2.20 – 2.40 PM |
Assessment and management of invasive fungal pneumonia. Speaker: Dr.Vinay V Bohara |
Acquired haemophilia. Speaker: Dr.Dinesh Chandra |
CAR-T cell therapy :Nurses preparedness and competencies to deliver care Speaker: Dr.Dhanalakshmi. J |
Sample collection, transport and storage Speaker: Dr.Narsimha |
2.40 – 3.00 PM |
Febrile neutropenia Speaker: Dr.Ambar Garg |
Bleeding with normal screening coagulogram Speaker: Dr.Rashmi Kushwaha |
Fecal Microbiota:How does it work? Speaker: TBA |
Oppurtunities for technologists in Hematology Speaker: Mr.Sitaram |
3.00 - 4.20 PM |
Session 13 - Immune cytopenia Chairpersons: Dr.PP Joshi, Dr.Chafle & Dr.Mrs Chand |
Session 14 - Disorders of bleeding Chairpersons: Dr.Sakhare ,Dr.Matte & Dr.Alka Thool |
Session 15 - Laboratory Haematology Chairpersons: Dr.Sabina Langer (SGRH) & Dr.Vandana Puri (LHMC) |
Session 16 - Apheresis Chairpersons: Dr.Harish Warbhe |
3.00-3.20 PM |
Approach to a patient of Neutropenia : Speaker: Dr.Shazia Gulshan |
Approach to the patient with DIC Speaker: Brig Dr. S. Venkatesan |
Laboratory monitoring of DOAC. Speaker: Dr.Abhishek Sharma |
Stem cell/DLI manipulation Speaker: Dr.Rizwan Javed |
3.20 – 3.40 PM |
AIHA - management Speaker: Dr.Aditi Jain |
Reversal of DOACS/Superwarfarin/Heparins Speaker: Dr.Subhaprakash Sanyal |
Lupus diagnosis: What clinician should know Speaker: Dr.Priyavadhana Balasubramanian |
Apheresis for SDP and granulocytes Speaker: Dr.Prashant Agrawal |
3.40 – 4.00 PM |
Immune Thrombocytopenia Speaker: Dr.Anil Irom |
Heavy Menstrual bleeding Speaker: Dr.Shruti Toshniwal |
Thrombophilia testing when to test whom to test and what to test Speaker: Brig.Bhushan Asthana |
Stem cell sources, collection and preservation Speaker: Dr.Mohandoss Murugesan |
4.00 – 4.20 PM |
Macrophage activation syndrome Speaker: Dr.Shriram Kane |
Warfarin and Heparin resistance - Approach Speaker: Dr.Hamza Dalal Mumbai |
Choosing Coagulation analyser- Smart way Speaker: Dr.Durga Devi MD DM |
AI in Transfusion medicine Speaker: Dr.Rounak Dubey |
4.20 – 4.40 PM |
Tea break |
|||
4.40 – 7.30 PM |
Session - 17 Chairperson: |
Session 18 Chairperson: Dr.Prerna Arora(MAMC), Dr.H Rama(Lucknow) & Dr.Ravi MD |
Session 19 Chairperson: Dr.Kumbhalkar, Dr.Manjusha Giri |
Session 20 Chairperson: Dr.Sarda & Dr.Sheela Mundhada |
4.40 – 5.00 PM |
Inauguration |
Peripheral smear - Science or art Speaker: Dr.Prabhu Manivannan (JIPMER) |
Iron Metabolism - updates Speaker: Dr.Preeti Tripathi |
Immune mediated hemolysis - Alloantibody identification Speaker: Dr.Chenna Deepika |
5.00 – 5.20 PM |
ICH-API session |
Hemolytic anemia: Lab approach Speaker: Dr.Bidyut K Swami |
Iron replacement - How to do it right Speaker: Dr.S P Verma |
Massive transfusion protocol Speaker: Dr.Somnath Mukherjee |
5.20 - 5.40 PM |
ICH-API session Speaker: Dr.Santosh Saraf(Chicago) |
Bone marrow : In whom, when, how, what Speaker: Dr.Amrita saraf |
Anemia of chronic diseases - Diagnosis and management Speaker: Dr.Manoj Toshniwal |
Pre and Post BMT transfusion - Transfusion medicine role Speaker: Dr.Soumya Das |
5.40 – 6.20 PM |
Session-21 Chairperson: |
Session-22 Chairperson: Dr.Sitaram Mohapatra, Dr.Manjit Rajput & Dr.Kishore deshpande |
Session-23 Chairperson: Dr.Khot, Dr.Kunal Chattani & Dr.Ashish Bohra (NCI) |
Session-24 Chairperson: Dr.Singhvi & Dr.Bhau Rajurkar |
5.40 – 6.00 PM |
Recurrent pregnancy loss – Obstetrics perspective
Speaker: |
Case bassed discussion on cell counter plots Speaker: Dr.Ankur Ahuja |
Approach to pancytopenia diagnosis: Causes of failed engine Speaker: Dr.Vijai Tilak |
Pre operative work up for bleeding disorder Speaker: Dr.Vandana Puri |
6.00 – 6.20 PM |
Recurrent pregnancy loss – Hematological perspective Speaker: |
How to choose cell counter when starting hematology lab Speaker: Dr.Gurmeet Singh (Bhilai) |
Aplastic anemia - Basics Speaker: Dr.Samir Kumar Behera |
Peri operative management in Sickle Cell disease Speaker: Dr.Biswaprakash Padri |
6.20 – 7.30 PM |
Session - 25 Indian college of Haematology AOP – Paeds Bleeding child Chairperson: |
Session - 26 Chairperson: Dr.Gurpreet Sagoo (AFMC), Dr.R K Banashree (JNMIS Imphal) & Dr.Sanjay Deotale |
Session - 27 Chairperson: Dr.Acharya, Dr.Swapna Khanjode & Dr.Manisha Mishra |
Session - 28 Chairperson: Dr.Varada Rajan R. & Dr.Gunjan Loney |
6.20 – 6.40 PM |
Thrombocytopenia - AOP Speaker: |
Approach to Thrombocytosis Speaker: Dr.Roopam Deka (AIIMS Guahati) |
How to identify MAHA Speaker: Dr.Abhishek Purohit |
Surgery in a patient on anticoagulants. Speaker: Dr.Akanksha garg |
6.40 – 7.00 PM |
Coagulopathy in pediatrics Speaker: Dr.Gaurav Chhabra |
Approach to Eosinophilia Speaker: Dr.Somnath Padhi |
Hematological emergencies in Obstetrics Speaker: Dr.Narendra M.Venkata Anukonda |
Anti coagulation in thrombocytopenic patients Speaker: Dr.Hitha Diljith |
7.00 – 7.20 PM |
Pancytopenia Speaker: |
Approach to Polycythemia Speaker: Dr.P. K Sasidharan |
HUS/TTP - Approach Speaker: TBA |
Anticoagulation in patients with organ dysfunction Speaker: Dr.Tejaswini Vaid |
7.30 – 8.30 PM |
Chairperson: |
Chairperson: |
Chairperson: |
Chairperson: Dr Mundhra shailendra, Dr Rasika Gadkari |
7.30 – 8.00 PM |
Panel Discussion on Leucocytosis Moderator: Dr.Shyam Agrawal |
Panel discussion on AIHA Moderator: TBA |
Panel discussion on Eosinophillia Moderator: TBA |
Newer application of flowcytometry Moderator: TBA |
8.00 – 8.30 PM |
Panel Discussion on high Hemoglobin : Moderator: Dr.Anil Singhvi |
Panel discussion on ITP Moderator: TBA |
Panel Discussion on Bleeeding in young female Moderator: TBA |
Choosing wisely - genetic testing tools in work up of hematological malignancy Moderator: TBA |
8.30 PM |
Dinner at : Centre point Hotel |
Scientific Agenda Conference Day – 1 |
||||
Time |
Hall A |
Hall B |
Hall C |
Hall D |
8.00-9.00 AM |
REGISTRATION AND MEET THE PROFESSOR |
REGISTRATION AND MEET THE PROFESSOR |
REGISTRATION AND MEET THE PROFESSOR |
REGISTRATION AND MEET THE PROFESSOR |
9.00 - 10.00 AM |
Oral Paper (Selected 6) |
Oral Paper (Selected 6) |
Oral Paper (Selected 6) |
Oral Paper (Selected 6) |
10.00 – 11.00 AM |
Session 29 |
Session 30 |
Session 31 |
Session 32 |
10.00 – 10.20 AM |
Unmet Research Need for SCD in India Dr Bontha V Babu Speaker: |
Hemophillia A - Prophylaxis in LMIC - Do's and Dont's Speaker: TBA |
TKD mutation analysis - updates Speaker: Dr.Neeraj Arora |
Allogeneic SCT - MSD, MUD, Haplo - LMIC challenges and solutions Speaker: Dr.Navin Khattry |
10.20 – 10.40 AM |
Pathophysiology and treatment of human hemolytic anemias Speaker: Dr.Mohandas Narla |
Optimising lab monitoring in hemophillia on newer products/ Role of chromogenic factor assay when to do and how to do Speaker: Dr.Sukesh Nair (CMC) |
Balancing the TKI equation - How much is enough ? Low dose vs TFR Speaker: Dr.Hemant Malhotra |
Infections in BMT Speaker: Dr.Sangeet Dadwal |
10.40 – 11.00 AM |
Transplants in Thalassemia - How to upscale to meet national demands : Speaker: Dr.Sunil Bhat |
Novel agents in Hemophilia Speaker: Dr.Aby Abraham |
Novel therapy /combinations in CML Speaker: Dr.Tapan Saikia |
HLA and donor specific antibodies - Methods and implications Speaker: Dr.Anil Handoo (MAX Delhi) |
11.00 - 11.15 AM |
Tea break |
|||
11.15 AM - 12.30 PM |
Session 33 - ISHBT-ASH Joint Symposium(Hall A) Myelodysplastic Syndrome Chairperson: Dr.Narla Mohan Das (Past President; ASH) and Dr.P K Sasidharan (President, ISHBT) |
11.15 AM - 11.35 AM |
Diagnostic and Genomics Approach for MDS Speaker: Dr.Uma Borate |
Session 33 - ISHBT-ASH Joint Symposium(Hall A)
|
Session 33 - ISHBT-ASH Joint Symposium(Hall A) |
Session 33 - ISHBT-ASH Joint Symposium(Hall A) |
11.35 AM - 11.55 AM |
Treatment of Low risk MDS Speaker: Dr.Tuphan Kanti Dolai (Hon. Secretary, ISHBT) |
Session 33 - ISHBT-ASH Joint Symposium(Hall A) |
Session 33 - ISHBT-ASH Joint Symposium(Hall A) |
Session 33 - ISHBT-ASH Joint Symposium(Hall A) |
11.55 AM - 12.15 PM |
Treatment of High Risk MDS Speaker: Dr.David Sallman |
Session 33 - ISHBT-ASH Joint Symposium(Hall A) |
Session 33 - ISHBT-ASH Joint Symposium(Hall A) |
Session 33 - ISHBT-ASH Joint Symposium(Hall A) |
12.15 AM - 12.30 PM |
Q & A |
Session 33 - ISHBT-ASH Joint Symposium(Hall A) |
Session 33 - ISHBT-ASH Joint Symposium(Hall A) |
Session 33 - ISHBT-ASH Joint Symposium(Hall A) |
12.30 - 1.00 PM |
ABBEVE Speaker: |
LMIC and Myeloma Speaker: Dr.Shaji |
Speaker: |
Speaker: |
01.00 - 1.30 PM |
|
Myeloma panel discussion Moderator: Dr.Arun VA Panelis: Dr.Shaji, rest TBA |
|
|
1.30 - 2.15 PM |
Lunch Break & Poster walk |
|||
2.15 – 3.15 PM |
Session 34 - Dr. J G Parekh Oration 2024 Setting up a contemporary coagulation lab: Challenges and the way forward Chairperson: Dr.Vikram Mathews,Dr.Tijender Singh Orator: Dr.Rakhee Kar |
Session 35-ISHBT-ASIAN Joint Symposium |
Session 36 - panel discussion (30 min each ) |
Session 37 - Panel discussion (30 min) |
2.15 - 2.45 PM |
- |
- |
MPN cases Moderator: Dr.Saurabh Bhave Panelis: TBA |
GVHD Moderator: TBA Panelis: TBA |
2.45 - 3.15 PM |
- |
- |
DIC |
Aplastic Anemia Moderator: Dr.Rishi Dhawan Panelis: TBA |
3.15 - 4.15 PM |
Session 38 - Session on Advances in Sickle Cell Disease Diagnosis and Therapy Chairperson: TBA |
Session 39- |
Session 40 - Chronic Lymphocytic Leukemia Chairperson: TBA |
Session 41 - Hemostasis, Laboratory and transfusion services Chairperson: TBA |
3.15 - 3.35 PM |
Integrated point of care / advances for rapid and cost- effective screening / confirmation for Hb Pathies Speaker: Dr.Prof.Unmut Gurkan, PhD. Case Western, USA |
AML - Genomic landscape and genetic predisposition Speaker: Dr.Nikhil Patkar |
Treatment strategies in CLL : Evolving frontline treatment /Dual-targeted regimens for the frontline treatment of CLL Speaker: Dr.Ramesh Pandita |
Lab diagnosis and nuances - von Willebrand disease Speaker: Dr.Jasmina Ahluwalia(PGI) |
3.35 - 3.55 PM |
New and Emerging Pharmacological Therapies for SCD: Do we have magic bullets or should the search continue? Speaker: Dr.Zenaide Quezado, |
AML diagnosis WHO 2022: How to apply in Indian settings Speaker: Dr.Jasmita Das |
Nuances/toxicities of targeted therapies in CLL : How to manage? Speaker: Dr.MB Agarwal |
Platelet dysfunction work up and troubleshooting nuances Speaker: Dr.Ruchi Gupta |
3.55 - 4.15 PM |
Curative therapies (bone marrow transplant and gene therapy)for the treatment of sickle cell disease: Benefits and challenges Speaker: Dr.John Tisdale, M.D.. |
AML - Personalised medicine from chemo to novel agents Speaker: Dr.Devendra Hiwase |
MRD directed therapy for CLL - Is it ready for prime time? Speaker: Dr.Kundan Mishra |
Evolving trends in microangiopathic hemolytic anemia TTP / HUS Speaker: |
4.15-4.30 PM |
Tea break |
|||
4.30-5.30 PM |
Session 42 Chairperson: /p> |
Session 43 - AML 2 Chairperson: /p> |
Session 44 - Mature B cell Lymphoma Chairperson: /p> |
Session 45 - Primary immune deficiencies Chairperson: /p> |
4.30-4.50 PM |
Advancing the research priorities for India-specific comorbidities of SCD (It could be from scientific and/or policy perspective) Speaker: Administrator |
AML - MRD monitoring - Is it ready for prime time? Speaker: Dr.Neha Singh |
Follicular Lymphoma - updates Speaker: TBA |
Primary immune deficiency - Lab Approach made easy Speaker: Dr.Manisha Madkaikar (Director NIIH Mumbai) |
4.50-5.10 PM |
New Information regarding SCD in India; Huge National Impact Speaker: Dr.R K Jena, India |
TP53 mutated myeloid neoplasm Speaker: Dr.Naval Daver |
Mantle Cell Lymphoma - Novel strategies/combinations Speaker: Dr.Rahul Bhargava |
PID - Infectious complications and management Speaker: Dr.Mukesh Desai |
5.10 PM - 5.30 PM |
National sickle cell disease mission of India: Promise, progress and beyond Speaker: Dr.Sanghamitra Pati, Addl. DG, ICMR, Delhi |
Relapsed AML - Best way forward? Speaker: Dr.Vikram Mathews |
Marginal zone lymphoma - Approach Speaker: Dr.Neeraj Sidharthan |
Special consideration in PID SCT Speaker: TBA |
5.30 - 6.30 PM |
Session 46 - Sickle Cell Disease Chairperson: - |
Session 47 - Myelodysplastic syndrome Chairperson: Dr. Afaq Ahmad Khan |
Session 48 - Aggressive lymphomas Chairperson: |
Session 49 - Rare hematological neoplasms Chairperson: |
5.30 - 5.50 PM |
Global Sickle Cell Disease Network (GSCDN): Goals for integration of a global approach for advancement of SCD treatment and care Speaker: Dr. Isaac Odame, |
Diagnosis of MDS- Recent updates Speaker: Dr.col. Jyoti Kotwal (SGRH) |
FCM approach to T CLPD- time to get away with TCR gene rearrangement Speaker: Dr.Kunal Sehgal |
BPDCN: update Speaker: Dr.Milli Shah UK(King's college) |
5.50 - 6.10 PM |
The journey towards India’s potential as a global leader for SCD Speaker: Dr.Kalpna Gupta, USA |
High risk MDS: Prognostication and Approach to management Speaker: Dr.Dharma Choudhary . |
Double hit lymphoma - optimizing therapy Speaker: Dr. Harimenon |
Novel therapeutic options for histiocytosis Speaker: Dr. Chepsy Phillips |
6.10 - 6.30 PM |
Unconventional treatments Speaker: Dr.Sukanya Gogoi |
Optical genome mapping - clinical relevance Speaker: Dr.D K MISHRA |
Molecular profiling in DLBCL - Clinical implications Speaker: Dr.Tathagat Chatterjee |
Advanced phase MPN clinical pearls Speaker: Dr.Aniket Bankar |
6.30 - 7.30 PM |
werfen Coag/ Transasia SCA |
Industry Symposium 10 |
Industry Symposium 11 |
Industry Symposium 12 |
7.30 - 8.00 PM |
Inauguration Ceremony (Centre Point) |
|||
8.00 PM |
Dinner - CP Hotel |
Scientific Agenda Conference Day – 2 |
||||
Time |
Hall A |
Hall B |
Hall C |
Hall D |
7.00 AM |
Walk for Haematology |
|||
8.00-9.00 AM |
REGISTRATION AND MEET THE PROFESSOR |
|||
9.00 - 10.00 AM |
Oral Paper (Selected 6) |
Oral Paper (Selected 6) |
Oral Paper (Selected 6) |
Oral Paper (Selected 6) |
10.00 - 11.00 AM |
National Haematology Quiz among the Post Doctoral Student |
Session 50-ALL Chairperson: |
Session 51 - Aplastic anemia Chairperson: |
Session 52 - Hodgkin Lymphoma Chairperson: |
10.00-10.20 AM |
National Haematology Quiz among the Post Doctoral Student |
Genetic work up in a case of ALL- Practical testing approach in LMIC Speaker: Dr.Mayur Parihar (TMC kolkata) |
Advances in the pathogenesis and treatment of Aplastic anaemia- clonality meets the immune system Speaker: Dr.G J Mufti |
Management of limited-stage Hodgkin lymphoma Speaker: Dr.Anu Korula |
10.20-10.40 AM |
National Haematology Quiz among the Post Doctoral Student |
Treatment of ALL in LMIC - targeting the lacunae Speaker: Dr.Narendra Agarwal |
Optimizing management of aplastic anemia with ACE therapy Speaker: Dr.Manoranjan Mahapatra |
Hodgkin lymphoma treatment for older persons Speaker: Dr. Nitin Gupta |
10.40-11.00 AM |
National Haematology Quiz among the Post Doctoral Student |
Car T vs allogeneic SCT - in primary progressive ALL/Mechanism of escape in CAR T Cell therapy Speaker: Dr.Vipul Seth |
SCT - special considerations in IBMF Speaker: Dr.Biju George |
The optimal management of relapsed and refractory Hodgkin lymphoma: post–brentuximab and checkpoint inhibitor failure Speaker: Dr.Rahul Naithani |
11.00 - 11.15 AM |
Coffee Break |
|||
11.15 AM - 12.30 PM |
Session 53 - ISHBT-EHA Joint Symposium 2024 (Hall A) Topic Immune Cytopenias Chairperson: Dr.Shanaz Khodaiji ( Immediate Past President; ISHBT) Dr.Sarmila Chandra (President Elect; ISHBT ) and Dr.Antonio Almeida (EHA President ; virtually) |
11.15 AM - 11.35 AM |
Immune hemolytic anemias Speaker: Dr. Bruno Fattizzo |
Session 53 - ISHBT-EHA Joint Symposium(Hall A) |
Session 53 - ISHBT-EHA Joint Symposium(Hall A) |
Session 53 - ISHBT-EHA Joint Symposium(Hall A) |
11.35 AM - 11.55 AM |
Immune Thrombocytopenia Speaker: Dr.Waleed Khalid Yosif Ghanima |
Session 53 - ISHBT-EHA Joint Symposium(Hall A) |
Session 53 - ISHBT-EHA Joint Symposium(Hall A) |
Session 53 - ISHBT-EHA Joint Symposium(Hall A) |
11.55 AM - 12.15 PM |
Immune Cytopenias in Children Speaker: Dr.Rahul Naithani |
Session 53 - ISHBT-EHA Joint Symposium(Hall A) |
Session 53 - ISHBT-EHA Joint Symposium(Hall A) |
Session 53 - ISHBT-EHA Joint Symposium(Hall A) |
12.15 AM - 12.30 PM |
Q & A |
Session 53 - ISHBT-EHA Joint Symposium(Hall A) |
Session 53 - ISHBT-EHA Joint Symposium(Hall A) |
Session 53 - ISHBT-EHA Joint Symposium(Hall A) |
12.30 - 1.30 PM |
Industry Symposium |
Industry Symposium |
Industry Symposium |
Industry Symposium |
1.30 - 2.15 PM |
Lunch Break & Poster walk |
|||
2.15 - 3.15 PM |
Session 54 - Dr. J B Chatterjea Oration 2024 Monocytosis.. Often more than meets the eye! Chairperson: Dr.H P Pati, Dr.Vijai Tilak Orator: Dr.Pankhi Dutta |
Session 55 - CART - 1 Chairperson: |
Session 56 - HLH Chairperson: |
Session 57 - Plasma Cell Disorders Chairperson: |
2.15 - 2.35 PM |
Bispecific CAR T cell Therapy in ALL Speaker: Prof Persis Amrolia |
Approach to HLH in adults Speaker: Dr.Sanjeevan Sharma |
MGUS, Smoldering myeloma and myeloma management - where to draw the line Speaker: Dr.Pankaj Malhotra |
|
2.35 - 2.55 PM |
In house point of care management with in ALL CAR Speaker: Arnon Nagler |
Primary HLH and Nuances of BMT Speaker: TBA |
Approach to paraproteinemia and Updates in myeloma diagnosis = Mass FIX in LMIC Speaker: Dr.Ritu Gupta |
|
2.55 - 3.15 PM |
Developments in CAR T in India Speaker: Dr.Gaurav Narula |
Novel Therapies/Advances in HLH Speaker: Dr.Balkrishna Padate |
Comprehensive clinico-genetic profiling of multiple myeloma patients in an Indian cohort: Insights and implications for precision medicine Speaker: Dr Bibhas Kar |
|
3.15 - 4.15 PM |
Session 58 - Plasma Cell Disorders 2 Chairperson: |
Session 59 - CART - 2 Chairperson: |
Session 60 - Complement and immune mediated diseases Chairperson: |
Session 61 - Anemia 2 Chairperson: |
3.15 - 3.35 PM |
MRD vs Peripheral blood myeloma monitoring Speaker: Dr.Prashant Tembhare |
CAR T cell Therapy in MM Speaker: Dr.Arnon Nagler |
TTP/HUS Speaker: Dr.Jitendra Khunger |
Anemia diagnosis- Solving riddle using newer hematopathology tools Speaker: Dr.Debdatta Basu |
3.35 - 3.55 PM |
Primary refractory and extra medullary disease - is there light at the end of the tunnel? Speaker: Dr. Uday Yanamandra |
In house local site CAR Manufacturing Speaker: Dr.Annalisa Ruggeri |
PNH Speaker: Dr.Pravas Mishra |
Auto immune hemolytic anemia - Management Speaker: Dr.Tuphan Kanti Dolai |
3.55 - 4.15 PM |
MGCS - MGRS, MGNS, POEMS, TEMPI Speaker: Dr.Jeevan Garg |
CAR T cell Therapy in AML Speaker: Prof.Persis Amrolia |
Cold Agglutinin Disease Speaker: Dr. Pankhi Dutta |
Lab approach to a case of cryoglobulinemia Speaker: Dr Richa Chauhan |
4.15-4.30 PM |
Tea Break + Poster walk |
|||
4.30-5.30 PM |
Session 62 - Dr. Malti Sathe Chairpersons: - |
Session 63 - Recognizing, defining, and managing unusual hematologic toxicities Chairpersons: |
Session 64 - Thrombosis Chairpersons: |
Session 65 - Inpatient Hematology Emergencies Chairpersons: |
4.30-4.50 PM |
Session 62 - Dr.Malti Sathe Oration 2024 Deciphering Temporal Progression and Clonal Hierarchies to Unveil Pathogenesis and Evolution in Multiple Myeloma forward Chairperson: Dr.Samira K Behera, Dr.Gurmeet Singh Orator: Dr.Ritu Gupta |
CRS and management of CART Toxicities Speaker: Dr.Annalisa Ru geri |
The dos, don'ts, and nuances of thrombophilia testing Speaker: Dr.Tara Roshni Paul |
Role of critical care medicine in hematology Speaker: Dr.Mukul Agarwal |
4.50-5.10 PM |
Session 62 - Dr. Malti Sathe Chairpersons: - |
Checkpoint inhibitors Speaker: Dr.Rayaz Ahmad |
How to diagnose and manage antiphospholipid syndrome Speaker: Dr.Shanaz Khodaji |
How to manage ITP with life-threatening bleeding Speaker: Dr.Priyanka Samal |
5.10-5.30 PM |
Session 62 - Dr. Malti Sathe Chairpersons: - |
Bispecific antibody therapies Speaker: Dr. Rajan Kapoor |
DOACs for acute DVT in patients with organ dysfunction Speaker: Dr. N V Ramaswamy |
Inpatient recognition and management of Hyperviscosity Speaker: TBA |
5.30 - 6.30 PM |
Session 66 - Plasma Cell Disorders 3 Chairperson: - |
Session 67 - Myelofibrosis Chairperson: |
Session 68- Bleeding Chairperson: |
Session 69- Things not talked about Chairperson: |
5.30 - 5.50 PM |
AL amyloidosis: Updates in diagnosis and management Speaker: Dr.Ashutosh Wechalekar |
Approach to diagnosis Speaker: Dr.Tejinder Singh |
How to assess and manage hemostasis in patients with severe liver disease during intervention/Liver transplantation Speaker: Dr.Maitryee Bhatacharya |
How to setup Hematology/BMT unit in public health center Speaker: Dr.Soniya Nityanand |
5.50- 6.10 PM |
Waldenstrom's Macroglobulinemia Speaker: Dr. Gaurav Prakash |
Transplant in Myelofibrosis - Art of balance Speaker: Dr. Rajat Kumar |
How to manage bleeding on novel agents for Hemophilia Speaker: Dr. Chandrakala |
AI in Hematologist's life Speaker: Dr. Prantar Chakrabarti |
6.10-6.30 PM |
When a hematologist becomes a Myeloma patient Speaker: Dr.Shafeek Salim UK |
Evolving landscape of JAK inhibition/Novel Therapies in MF Speaker: Dr.Mallikarjun Kalashetty |
When to suspect, how to diagnose and manage acquired VWD Speaker: Dr.Mrinalini Kotru |
How to strike a balance between clinical responsibilities and research in India Speaker: Dr.Joseph John |
6.00 - 7.00 PM |
Servier On IDH Inhibitor |
Industry Symposium 18 |
Industry Symposium 19 |
Industry Symposium 20 |
7.00 - 8.00 PM |
Annual GBM Hall - A |
|||
8.00 PM |
Gala Dinner at : River Front |
Scientific Agenda Conference Day – 3 |
||||
Time |
Hall A |
Hall B |
Hall C |
Hall D |
7.00-8.00 AM |
Meet the professor |
|||
8.00-9.00 AM |
NATIONAL HEMATOLOGY ISHBT QUIZ FINAL |
|||
9.00am to 10.00 AM |
Oral Paper (Selected 6) |
Oral Paper (Selected 6) |
Oral Paper (Selected 6) |
Oral Paper (Selected 6) |
10.00-10.15 AM |
Tea Break |
|||
10.15-11.45 AM |
Session 70 - Dr. J C Patel Award Session (Hall A) |
|||
11.45-12.45 PM |
Session 71 - Interesting case Based Learning (Clinical-15 mins Each) |
Session 72 - Interesting case Based Learning (Laboratory-15 mins Eachr) |
Session 73 - Consultative Haematology-1 |
Session 74 - Consultative Haematology-2 |
11.45-12.00 PM |
Inherited bone marrow failure Speaker: Dr.Gaurav Dhingra |
Haemolytic anaemia Speaker: Richa Gupta |
Unusual site thrombosis - Approach Speaker: Dr.Abhijeet Ganapule |
Isolated PT/APTT prolongation - Approach Speaker: Dr.Sunita Sharma |
12.00-12.15 PM |
HSCT complication Speaker: TBA |
MDS/AML Speaker: Dr.Arpan Mehta |
Iron metabolism updates and approach to Iron deficiency Speaker: Dr.Kanjaksha Ghosh |
Von willebrand - Peri partum management Speaker: TBA |
12.15-12.30 PM |
Immune thrombocytopenia Speaker: TBA |
ALL Speaker: Dr.Anita Chopra AIIMS |
Thrombocytosis/Polycythemia - Approach Speaker: Dr. Avinash Singh |
Heavy Menstrual bleeding - Approach Speaker: Dr.Debmalya Bhattacharya |
12.30-12.45 PM |
Acute Myeloid Leukemia Speaker: TBA |
CLPD Speaker: Dr.Sudha Shetty |
Deep vein thombosis - Approach Speaker: TBA |
Peri operative management of anticoagulation - Approach Speaker: Dr.Suvir Singh |
12.45-1.45 PM |
Session 75 - Bench to bed side : Chairpersons: |
Session 76 - Debate Chairpersons: |
Session 77 - Consultative Haematology-3 Chairpersons: |
Session 78- Consultative Haematology - 4 Chairpersons: |
12.45-1.05 PM |
NGS work up of hemolytic anemia Speaker: Dr.Prashant Sharma |
Debate 1 - (12 mins +12 mins + 6 mins) Role of MRD in myeloma in clinical setting Speaker: Yes: Dr. Sumeet Mirgh No: TBA |
Management of DIC Speaker: Dr.Archit Pandharipande |
Abnormal blood counts in pregnancy? Speaker: Dr.Upendra Sharma |
1.05 - 1.25 PM |
How to optimise IBMF diagnosis in era of NGS -Which test to order Speaker: Dr.Ganesh Kumar Vishwanthan (AIIMS Delhi) |
Debate 2 - 15mins +15 mins +5 mins: Immunotherapy in hodgkin disease replaces SCT Speaker: Yes: TBA No: TBA |
Management of intracranial bleed in ITP Speaker: Dr.Santanu Basu |
Anticoagulation in pregnancy Speaker: Dr.Jina bhattacharya |
1.25 - 1.45 PM |
"Genetic Profiling in B-Cell Acute Lymphoblastic Leukemia (B-ALL): Laboratory Workup for Personalized Total Therapy" Speaker: Dr.Sanjeev Kumar Gupta |
Debate 2 - (12 mins +12 mins + 6 mins : Immunotherapy in hodgkin disease replaces SCT Speaker: Yes: TBA No: TBA |
Leukocytosis - Approach Speaker: Dr.Asif Iqbal |
Anemia in pregnancy Speaker: Dr.Subbaiah |
1.45 PM Onwards |
VALEDICTORY FUNCTION AND PRIZE DISTRIBUTION FOLLOWED BY LUNCH |